Research ArticleTheranostics
Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik Giesel, Walter Mier, Frederik Marme, Jürgen Debus and Uwe Haberkorn
Journal of Nuclear Medicine October 2020, 61 (10) 1507-1513; DOI: https://doi.org/10.2967/jnumed.119.239731
Thomas Lindner
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Annette Altmann
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
Susanne Krämer
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Christian Kleist
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Anastasia Loktev
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
Clemens Kratochwil
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Frederik Giesel
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Walter Mier
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
Frederik Marme
3Translational Gynecologic Oncology, University Hospital Mannheim, Mannheim, Germany; and
Jürgen Debus
4Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany
5Clinical Cooperation Unit Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany
Uwe Haberkorn
1Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg Germany
2Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany
6Translational Lung Research Center Heidelberg, German Center for Lung Research (DZL), Heidelberg, Germany
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 61, Issue 10
October 1, 2020
Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik Giesel, Walter Mier, Frederik Marme, Jürgen Debus, Uwe Haberkorn
Journal of Nuclear Medicine Oct 2020, 61 (10) 1507-1513; DOI: 10.2967/jnumed.119.239731
Design and Development of 99mTc-Labeled FAPI Tracers for SPECT Imaging and 188Re Therapy
Thomas Lindner, Annette Altmann, Susanne Krämer, Christian Kleist, Anastasia Loktev, Clemens Kratochwil, Frederik Giesel, Walter Mier, Frederik Marme, Jürgen Debus, Uwe Haberkorn
Journal of Nuclear Medicine Oct 2020, 61 (10) 1507-1513; DOI: 10.2967/jnumed.119.239731
Jump to section
Related Articles
Cited By...
- Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies
- Fibroblast Activation Protein Inhibitor-Based Radionuclide Therapies: Current Status and Future Directions
- Clinical Translation of Targeted {alpha}-Therapy: An Evolution or a Revolution?
- Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities
- Clinical Translation of Targeted {alpha}-Therapy: An Evolution or a Revolution?
- Albumin Binder-Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy
- Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of 68Ga-Labeled FAPI Dimer
- FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology?